• 제목/요약/키워드: Peroxisome proliferator-activated receptor

검색결과 461건 처리시간 0.043초

Bioinformatic analyses reveal the prognostic significance and potential role of ankyrin 3 (ANK3) in kidney renal clear cell carcinoma

  • Keerakarn Somsuan;Siripat Aluksanasuwan
    • Genomics & Informatics
    • /
    • 제21권2호
    • /
    • pp.22.1-22.15
    • /
    • 2023
  • Kidney renal clear cell carcinoma (KIRC) is one of the most aggressive cancer type of the urinary system. Metastatic KIRC patients have poor prognosis and limited therapeutic options. Ankyrin 3 (ANK3) is a scaffold protein that plays important roles in maintaining physiological function of the kidney and its alteration is implicated in many cancers. In this study, we investigated differential expression of ANK3 in KIRC using GEPIA2, UALCAN, and HPA databases. Survival analysis was performed by GEPIA2, Kaplan-Meier plotter, and OS-kirc databases. Genetic alterations of ANK3 in KIRC were assessed using cBioPortal database. Interaction network and functional enrichment analyses of ANK3-correlated genes in KIRC were performed using GeneMANIA and Shiny GO, respectively. Finally, the TIMER2.0 database was used to assess correlation between ANK3 expression and immune infiltration in KIRC. We found that ANK3 expression was significantly decreased in KIRC compared to normal tissues. The KIRC patients with low ANK3 expression had poorer survival outcomes than those with high ANK3 expression. ANK3 mutations were found in 2.4% of KIRC patients and were frequently co-mutated with several genes with a prognostic significance. ANK3-correlated genes were significantly enriched in various biological processes, mainly involved in peroxisome proliferator-activated receptor (PPAR) signaling pathway, in which positive correlations of ANK3 with PPARA and PPARG expressions were confirmed. Expression of ANK3 in KIRC was significantly correlated with infiltration level of B cell, CD8+ T cell, macrophage, and neutrophil. These findings suggested that ANK3 could serve as a prognostic biomarker and promising therapeutic target for KIRC.

A Novel PPARγ Agonist, SP1818, Shows Different Coactivator Profile with Rosiglitazone

  • Park, Yun-Sun;Choi, Ji-Won;Kim, Kun-Yong;Lim, Jong-Seok;Yoon, Suk-Joon;Yang, Young
    • Biomolecules & Therapeutics
    • /
    • 제18권1호
    • /
    • pp.77-82
    • /
    • 2010
  • Peroxisome proliferator-activated receptor $\gamma$ (PPAR${\gamma}$) is a ligand-activated transcription factor that is used as a target for anti-diabetic drug development. In a search for novel PPAR${\gamma}$ agonists, the $\beta$-carboxyethyl-rhodanine derivative SP1818 was identified. We report here the characteristics of SP1818 as a selective PPAR${\gamma}$ agonist. In transactivation assays, SP1818 selectively activated PPAR${\gamma}$, but the degree of PPAR${\gamma}$ stimulation was less than with $1{\mu}M$ rosiglitazone. SP1818 also stimulated glucose uptake in a concentration-dependent manner. The adipocyte differentiation markers adiponectin, scavenger receptor CD36 and aP2 were weakly induced by treatment with SP1818, and TRAP220 subunit was specifically recruited into PPAR${\gamma}$ activated by rosiglitazone but not PPAR${\gamma}$ activated by SP1818.

Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1), leads to mitochondrial aberrations in mouse fibroblast NIH/3T3 cells

  • Im, Chang-Nim;Seo, Jeong-Sun
    • BMB Reports
    • /
    • 제47권5호
    • /
    • pp.280-285
    • /
    • 2014
  • Cancer cells undergo uncontrolled proliferation, and aberrant mitochondrial alterations. Tumor necrosis factor receptor-associated protein 1 (TRAP1) is a mitochondrial heat shock protein. TRAP1 mRNA is highly expressed in some cancer cell lines and tumor tissues. However, the effects of its overexpression on mitochondria are unclear. In this study, we assessed mitochondrial changes accompanying TRAP1 overexpression, in a mouse cell line, NIH/3T3. We found that overexpression of TRAP1 leads to a series of mitochondrial aberrations, including increase in basal ROS levels, and decrease in mitochondrial biogenesis, together with a decrease in peroxisome proliferator-activated receptor gamma coactivator-$1{\alpha}$ (PGC-$1{\alpha}$) mRNA levels. We also observed increased extracellular signal-regulated kinase (ERK) phosphorylation, and enhanced proliferation of TRAP1 overexpressing cells. This study suggests that overexpression of TRAP1 might be a critical link between mitochondrial disturbances and carcinogenesis.

지방분화시 PPARγ에 의한 microRNA-17의 발현 조절 (Transcriptional Regulation of MicroRNA-17 by PPARγ in Adipogenesis)

  • 배인선;김현지;정기용;최인호;김상훈
    • 생명과학회지
    • /
    • 제24권3호
    • /
    • pp.323-328
    • /
    • 2014
  • MicroRNA는 21~25개의 뉴클레오티드로 이루어진 단일 염기가닥의 RNA로 지방분화를 포함한 세포내 여러 생리학적 기전에 영향을 미친다. MicroRNA-17 (miR-17)은 지방전구세포의 지방분화를 촉진하고, 세포 내 지방을 축적시킨다. 그렇지만, 지방분화시 miR-17 전사조절 기전은 알려진 것이 없다. 본 연구에서는 $PPAR{\gamma}$ 전사인자가 miR-17의 전사를 조절하는지 여부를 조사하였다. 먼저 지방전구세포의 분화를 유도한 다음 $PPAR{\gamma}$와 miR-17의 발현을 조사한 결과 두 유전자 모두 분화 이후 발현이 증가하였다. 또한 miR-17 프로모터 부위에는 $PPAR{\gamma}$ 반응하는 부위(PPRE)가 세 군데 발견되었다. Chromatin immunoprecipitation과 luciferase assay을 실시한 결과, miR-17 프로모터의 PPRE3 (-677/-655) 부위가 $PPAR{\gamma}$와 직접 결합함을 관찰하였다. 이러한 연구 결과는 3T3-L1 세포주에서 $PPAR{\gamma}$가 miR-17의 전사를 활성화 시키고 있음을 나타낸다. 향후 $PPAR{\gamma}$에 의한 표적 microRNA을 대량 발굴한다면 비만과 관련한 $PPAR{\gamma}$의 기능을 보다 구체적으로 파악하는데 중요한 정보를 제공할 수 있을 것으로 생각된다.

Ameliorative effects of black ginseng on nonalcoholic fatty liver disease in free fatty acid-induced HepG2 cells and high-fat/high-fructose diet-fed mice

  • Park, Miey;Yoo, Jeong-Hyun;Lee, You-Suk;Park, Eun-Jung;Lee, Hae-Jeung
    • Journal of Ginseng Research
    • /
    • 제44권2호
    • /
    • pp.350-361
    • /
    • 2020
  • Background: Black ginseng (BG) is a type of Korean ginseng prepared by steaming and drying raw ginseng to improve the saponin content. This study examined the effects of BG on nonalcoholic fatty liver disease (NAFLD) in HepG2 cells and diet-induced obese mice. Methods: HepG2 cells were treated with free fatty acids to induce lipid accumulation before supplementation with BG. NAFLD-induced mice were fed different doses (0.5%, 1%, and 2%) of BG for 8 weeks. Results: BG significantly reduced lipid accumulation and expression of lipogenic genes, peroxisome proliferator-activated receptor gamma, CCAAT/enhancer-binding protein alpha, sterol regulatory element-binding protein-1c, and fatty acid synthase in HepG2 cells, and the livers of mice fed a 45% high-fat diet with 10% fructose in the drinking water (HFHF diet). BG supplementation caused a significant reduction in levels of aspartate aminotransferase and alanine aminotransferase, while antioxidant enzymes activities were significantly increased in 45% high-fat diet with 10% fructose in the drinking water diet-fed mice. Expression of proliferator-activated receptor alpha and carnitine palmitoyltransferase I were upregulated at the transcription and translation levels in both HepG2 cells and diet-induced obese mice. Furthermore, BG-induced phosphorylation of AMP-activated protein kinase and acetyl CoA carboxylase in both models, suggesting its role in AMP-activated protein kinase activation and the acetyl CoA carboxylase signaling pathway. Conclusion: Our results indicate that BG may be a potential therapeutic agent for the prevention of NAFLD.

Synthesis and biological activity of novel substituted pyridines and purines containing 2,4-thiazolidinedione

  • Kim, Bok-Young;Ahn, Joong-Bok;Lee, Hong-Woo;Kim, Joon-Kyum;Shin, Jae-Soo;Kang, Sung-Kwon;Lee, Jung-Hwa;Ahn, Soon-Kil;Lee, Sang-Jun;Hong, Chung-Il;Yoon, Seung-Soo
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2-2
    • /
    • pp.187.1-187.1
    • /
    • 2003
  • Type 2 diabetes is characterized by high level of blood glucose and insulin and impaired action. In recent years, the treatment of type 2 diabetes has been revolutionized with the advent of thiazolidinedione (TZD) class of molecules that ameliorate insulin resistance and thereby normalize elevated blood glucose levels. These TZDs are synthetic, high-affinity ligands of peroxisome proliferator activated receptor-gamma (PPAR${\gamma}$); a member of the nuclear receptor family that controls the expression of genes in the target tissues of insulin action. (omitted)

  • PDF

Synthesis and Biological Activity of [[(Heterocycloamino)alkoxy] benzyl]-2,4-thiazolidinediones as $PPAR_\gamma$ Agonists

  • Jeon Raok;Kim Yoon-Jung;Cheon Ye-Jin;Ryu Jae-Ha
    • Archives of Pharmacal Research
    • /
    • 제29권5호
    • /
    • pp.394-399
    • /
    • 2006
  • Benzothiazole derivatives of thiazolidinediones (TZD) were synthesized using a modified Mitsunobu reaction of 2-(benzothiazol-2-ylmethylamino)ethanol (2) with 5-(4-hydroxybenzyl)-3-triphenylmethylthiazolidine-2,4-dione and assayed for activity on peroxisome proliferator-activated receptor (PPAR) subtypes and inhibitory activity of NO production in lipopolysaccharide-activated macrophages. Most of the tested compounds were identified as potent $PPAR_\gamma$ agonists, indicating their potential as drug candidates for diabetes.

고지방식이 유발 제2형 당뇨모델 마우스에서 작약의 혈당강하 효능 (Hypoglycemic Effect of Paeonia lactiflora in High Fat Diet-Induced Type 2 Diabetic Mouse Model)

  • 윤인수;정유정;김현정;임현진;조승식;심정현;강복윤;천승훈;김수남;윤구
    • 생약학회지
    • /
    • 제45권3호
    • /
    • pp.194-199
    • /
    • 2014
  • The roots of Paeonia lactiflora (PL) has been traditionally used as analgesic, spasmolytic and tonic in Korea, China, and Japan. As part of a search for herbal medicine to treat diabetes and obesity, we confirmed hypoglycemic effect of PL through high fat diet-induced obese and diabetic mice experiments in vivo. Treatment of ethanolic extract from PL led to a significant decrease in glucose level, which is comparable to that of an antidiabetic drug metformin. In addition, PL selectively stimulates the transcriptional activities of both peroxisome proliferator-activated receptor $(PPAR){\alpha}$ and ${\gamma}$, and inhibits enzymatic activity of protein tyrosine phosphatase 1B (PTP1B), which are predicted to be therapeutic target in treatment of type2 diabetes and obesity. Especially, the n-hexane fraction (Hx) from PL ethanol extract showed more potent activities on $PPAR{\alpha}$ and than others and exihibited moderate inhibitory activity against PTP1B.

초임계 추출 계피오일의 3T3-L1 지방전구세포의 분화 전사인자 억제에 의한 지방대사 조절 (Inhibition of Adipocyte Differentiation and Adipogenesis by Supercritical Fluid Extracts and Marc from Cinnamomum verum)

  • 박성진;이삼빈;이인선;유미희
    • 생명과학회지
    • /
    • 제23권4호
    • /
    • pp.510-517
    • /
    • 2013
  • 본 연구에서는 초임계를 이용한 계피 오일 추출물(SFC)과 오일 추출 후 남은 부산물인 박(SFM), 그리고 80% methanol (ME) 계피추출물을 이용하여 항비만 효과를 비교하고 어떤 계피의 어떤 성질의 성분이 비만에 더 효과적인지 알아보았다. 3T3-L1 preadipocyte의 성숙한 지방세포로 분화시키기 위해 iso-butylmethylanthine (IBMX), dexamathasone, insulin을 SFC, SFM, ME를 처리하고 Real time PCR을 이용하여 전사인자 발현을 확인하였다. 그 결과 SFC에서 mRNA 수준에서 peroxisome-proliferators-activated-receptor-${\gamma}$ ($PPAR{\gamma}$), CCAAT enhancer-binding-protein ${\alpha}$ ($C/EBP{\alpha}$)의 저해능이 세 가지 조건 중에서 가장 높았으며, 또한 SFC는 peroxisome-proliferators-activated-receptor-${\gamma}$ ($PPAR{\gamma}$), CCAAT enhancer-binding-protein ${\alpha}$ ($C/EBP{\alpha}$) sterol-regulatory-element-binding protein-1c (SREBP1c)와 acyl-CoA synthetase-1 (ASC1), fatty acid synthesis (FAS), fatty acid transport-1 (FATP1), fatty acid binding protein-4 (FABP4) 그리고 perilipin의 전사인자도 농도유의적으로 감소시켰다.

Expression of peroxisome proliferator activated receptor gamma in the neuronal cells and modulation of their differentiation by PPAR gamma agonists

  • Hong, Jin-Tae
    • 한국환경성돌연변이발암원학회:학술대회논문집
    • /
    • 한국환경성돌연변이발암원학회 2002년도 Molecular and Cellular Response to Toxic Substances
    • /
    • pp.14-40
    • /
    • 2002
  • 15-Deoxy-${\Delta}^{12, 14}$-prostaglandin $J_2$ (15-deoxy-$PGJ_2$), a naturally occurring ligand activates the peroxisome proliferator-activated $receptor-{\gamma}(PPAR-{\gamma}$). Activation of $PPAR-{\gamma}$ has been found to induce cell differentiation such as adipose cell and macrophage. Here it was investigated whether 15-deoxy-$PGJ_2$ has neuronal cell differentiation and possible underlying molecular mechanisms. Dopaminergic differentiating PC 12 cells treated with 15-deoxy-$PGJ_2$ (0.2 to 1.6 ${\mu}M$) alone showed measurable neurite extension and expression of neurofilament, markers of cell differentiation. However much greater extent of neurite extension and expression of neurofilament was observed in the presence of NGF (50 ng/ml). In parallel with its increasing effect on the neurite extension and expression of neurofilament, 15-deoxy-$PGJ_2$ enhanced NGF-induced p38 MAP kinase expression and its phosphorylation in addition to the activation of transcription factor AP-1 in a dose dependent manner. Moreover, pretreatment of SD 203580, a specific inhibitor of p38 MAP kinase inhibited the promoting effect of 15-deoxy-$PGJ_2$(0.8 ${\mu}M$) on NGF-induced neurite extension. This inhibition correlated well with the ability of SB203580 to inhibit the enhancing effect of 15-deoxy-$PGJ_2$ on the expression of p38 MAP kinase and activation of AP-1, The promoting ability of 15-deoxy-$PGJ_2$ did not occur through $PPAR-{\gamma}$, as synthetic PPAR-${\gamma}$ agonist andantagonist did not change the neurite promoting effect of 15-deoxy-PGJ$_2$. In addition, contrast to other cells (embryonic midbrain and SK-N-MC cells), $PPAR-{\gamma}$ was not expressed in PC-12 cells. Other structure related prostaglandins, PGD$_2$ and $PGE_2$ acting via a cell surface G-protein-coupled receptor (GPCR) did not increase basal or NGF-induced neurite extension. Moreover, GPCR (EP and DP receptor) antagonists did not alter the promoting effect of f 5-deoxy-$PGJ_2$ on neurite extension and activation of p38 MAP kinase, suggesting that the promoting effect of 15-deoxy-$PGJ_2$ may not be mediated GPCR. These data demonstrate that activation of p38 MAP kinase in conjunction with AP-1 single pathway may be important in the promoting activity of 15-deoxy-$PGJ_2$ cells.

  • PDF